In 2019, the Indian government implemented the "2019 Prohibition of Electronic Cigarettes Act," which banned the production, import, export, transportation, sale, or advertisement of e-cigarettes, considered as an alternative smoking device. These products are sold globally and are subject to appropriate regulatory controls, serving as a viable and less harmful option for consumers compared to other legally available tobacco products in India. Why was this irrational ban hurriedly imposed? Why does this discriminatory measure restrict consumers' basic right to make informed choices and not include e-cigarettes on the list of existing tobacco products? We must pose these questions to legislators because this unjustified ban is not only arbitrary but also unfair to citizens.
The government's concern is justified as they have been implementing anti-tobacco measures relentlessly in line with the regulations set forth in the 2003 COTPA and the first global health treaty, the Framework Convention on Tobacco Control (FCTC), by introducing warning labels and educating people. One of the main concerns of the government is that alternative products are becoming a gateway for young people and will only lead to another form of addiction.
However, on the contrary, it has been observed that unreasonable bans encourage the acquisition of unsafe products and allow young people and legal consumers to use non-compliant products in an unregulated manner. The serious issue is that the government has lost all forms of control over these underground products. There are many reports indicating that India is selling unqualified and potentially dangerous products on the black market.
It has been observed that most countries have classified all such "substitutes" as products with less harm under regulatory supervision and "suitable for protecting public health". The recent development is in the Philippines, where the country's policy towards such products has made a 180-degree shift.
In the Philippines, the sale of such products is allowed but not regulated. E-cigarettes are classified as "health-related devices" and require medical approval from the FDA for regulation. However, due to the strict regulations imposed by agencies such as the Food and Drug Administration, obtaining the necessary license application has many limitations. If such products are not restricted from use by minors, they cannot be regulated as consumer goods. Therefore, some suggest that they be regulated similarly to tobacco products. Additionally, organizations such as the UK Public Health Department and the British Lung Foundation emphasize the importance of regulating e-cigarettes in a manner different from traditional cigarettes. Furthermore, the medical community acknowledges that widespread use of such alternative products can be a component of reducing harm.
The Philippines has established a comprehensive regulatory framework for the import, manufacture, sale, promotion, distribution, use, and dissemination of electronic cigarette products, including e-cigarettes and heated tobacco products. This framework reflects the principle of proportionate risk regulation. For example, it has established different health warnings for non-combustible products compared to cigarettes. The Department of Trade and Industry has been tasked with collaborating with the FDA to develop technical standards for the safety, consistency, and quality of electronic cigarette products. The DTI has also been authorized to regulate the devices for nicotine and non-nicotine-containing products, as well as new tobacco products made from tobacco or containing nicotine.
Statement:
This article is compiled based on third-party information and is for industry exchange and learning purposes only.
This article does not represent the view of 2FIRSTS and 2FIRSTS cannot confirm the truthfulness and accuracy of the content. The translation of this article is only for industry communication and research purposes.
Due to limitations in translation abilities, the compiled article may not express the original text accurately. Please refer to the original text for accuracy.
2FIRSTS aligns completely with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, and foreign-related statements and positions.
The copyright of the compiled information belongs to the original media and author. If there is any infringement, kindly contact us for removal.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
